Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's balance sheet when you examine how risky it is, since debt is often involved when ...

When researching a stock for investment, what can tell us that the company is in decline? When we see a declining return on capital employed (ROCE) in conjunction with a declining base of capital ...

Compumedics has displayed significant magnetoencephalography (MEG) recordings optimized for pediatrics from the system successfully installed at Tianjin Normal University (TJNU) in China. This ...

Compumedics achieves record revenue of $51 million and sales orders of $63.4 million in FY25 Company returns to profitability, with EBITDA of ~$3 million and sleep and neurology segment orders up 439% ...

Compumedics Limited (AU:CMP) has released an update. Compumedics Limited bolsters its U.S. presence with the appointment of Craig Gallivan as National Vice President of Sales for its Home Sleep ...

Compumedics founder David Burton says brain imaging can rival the magnetic resonance imaging (MRI) market Having recently gained FDA approval, the company is eyeing the emerging US home sleep testing ...

Compumedics Limited (AU:CMP) has released an update. Compumedics Limited projects a record-breaking year with over $50 million in sales orders and at least $46 million in revenue for FY24, driven by ...

Compumedics has received FDA approval to market Falcon, its second home sleep testing solution in the US, with potential to substantially boost its revenue. Don't miss out on the headlines from ...

MELBOURNE, Australia--(BUSINESS WIRE)--Compumedics Limited (ASX: CMP), a world leading supplier of innovative medical technology for patient monitoring, has in collaboration with Beijing Fistar and ...

Compumedics (ASX:CMP) said the last financial year laid a stronger more scalable business model for FY26 and beyond with record sales orders of $63.4 million, up 22% on FY24. EBITDA increased to ~$3m, ...

Don't miss out on the headlines from Stockhead. Followed categories will be added to My News. If the home-grown player in cognitive and sleep analysis achieves this, Compumedics will have completed ...

Compumedics delivers breakout performance in FY25 with record revenue and sales orders, a return to profitability, and accelerating growth in the US and SaaS segments. Compumedics (ASX:CMP) said the ...